期刊文献+

人乳头瘤病毒感染亚型与宫颈病变的关系 被引量:8

Analysis of the Relationships between the Different Subtypes of Human Papillomavirus Infection and Cervical Lesions
下载PDF
导出
摘要 目的:探讨HPV感染与宫颈病变发生的关系。方法将病理检查确诊宫颈有病变的187例患者分为3组:慢性炎症组(n=41)、宫颈上皮瘤变(CIN)组(n=62)和宫颈癌组(n=84)。采用人乳头瘤病毒核酸扩增分型技术对患者宫颈脱落细胞样本作HPV基因分型检测,分析HPV感染状况及HPV基因型在各组疾病中的分布。结果 1187例患者中共检出HPV阳性者136例,阳性率为72.72%(136/187),其中高危型HPV感染阳性率为95.58%(130/136)。在被测的21个HPV亚型中最常见的6个类型依次为16型(46.32%、63/136),58型(21.32%、29/136),52型(15.44%、21/136),18型(12.50%、17/136),33型(9.56%、13/136),31型(8.09%、11/136),未检测出44型、43型及6型。2慢性炎症组HPV阳性率为14.63%(6/41);CIN组HPV阳性率为85.48%(53/62)、其中CINⅠ组、CINⅡ组、CINⅢ组中HPV感染率分别为62.50%(10/16)、90.47%(19/21)、96.00%(24/25);宫颈癌组HPV阳性率91.67%(77/84)。CIN及宫颈癌组HPV阳性率均高于炎症组,而CINⅡ~CINⅢ组及宫颈癌组HPV阳性率又明显高于CINⅠ组。3组阳性表达率差异有统计学意义(P<0.05)。3HPV阳性者中单一感染率为67.65(92/136),多重感染率为32.35%(44/136),其中以双重感染为主,占79.55%(35/44)。4HPV感染患者年龄以30~59岁最高,但各年龄段HPV感染检出率比较无统计学差异(P>0.05)。5慢性炎症组、CIN组和宫颈癌组的16型感染率分别为16.67%(1/6)、47.16%(25/53)、48.05%(37/77)。CIN组和宫颈癌组的16型感染率高于慢性炎症组,差异具有统计学意义(P<0.05)。结论 HPV感染与宫颈病变发生、发展密切相关,HPV基因分型诊断对宫颈病变高危人群的筛查、预防、临床诊断、治疗可提供重要的理论依据。 Objective To discuss the relation between human papillomavirus ( HPV) infection and the pathogenes of cervical lesions.Methods 187 cases of pathologically confirmed cervical lesions were divided into 3 groups,chronic flammation (n=41) group,cervical intraepithelial neoplasia (CIN)(n=62) group and cervical cancer (n=84)group.The characterization of genotypes of HPV in cervical cells was detected by human papillomavirus PCR method ( Kaipu) ,and the situation of HPV in-fection and distribution of genotypes of HPV in patients of each group were analyzed .Results 136 patients were infected with HPV,the positive rate was 72.72%(136/187),and 87 patients were infected with HR-HPV(high risk HPV,95.58%). HPV-16(46.32%,63/136) was the most common of the 21 subtypes of HPV,followed by subtypes HPV-58(21.32%,29/136),HPV-52(15.44%,21/136),HPV-18(12.50%,17/136),HPV-33(9.56%,13/136),HPV-31(8.09%,11/136),and there was no HPV-44 or HPV-43 or HPV-6.The positive rate of HPV in chronic flammation group was 14.63%(6/41),The positive rate of HPV in group of patients with CIN was 85.48%(53/62),and the positive rate of HPV in each typing of CINⅠ、CINⅡ、CINⅢwas 62.50%(10/16)、90.47%(19/21)、96.0%(24/25).The positive rate of HPV in group of patiens with cervical cancer was 91.67%(77/84).CIN level and cervical cancer patients of poitive rate of HPV were significantly higher than patients with cervi -cal disease ,and the positive rates of HPV in CIN Ⅱ~Ⅲlevel and cervical cancer group were significantly higher than type CINⅠgroup.The positive rates of the 3 groups were statistically different .HPV-positive rate was 67.65 in single infection ( 92/136),mixed infection rate was 32.35%(44/136),of which dual infection (35/44) rate was 79.55%.The peak age of HPV in-fection was 30-59 years old,there was no significant difference in the HPV-positive rates between each group (P<0.05).HPV-16 infection rates of the chronic in flammation,cervical in traepithelial neoplasia and cervical cancer group were 16.67%(1/6),47.16%(25/53)、48.05%(37/77),respectively.HPV-16 infection rates in cervical in traepithelial neoplasia and cervical canc-er group were higher than that of chronic in flammation group ,there was significant difference in the positive rate results .( P<0.05).Conclusion HPV infection is closely associated with occurrence and development of cervical lesions ,the characterization of HPV-DNA typing can provide significant theoretical basis for screening ,prevention ,cure and clinical diagnosis of high risk pop-ulation .
机构地区 江西省肿瘤医院
出处 《实用癌症杂志》 2014年第12期1540-1543,共4页 The Practical Journal of Cancer
关键词 人乳头瘤病毒 宫颈病变 基因分型 Human papillomavirus ( HPV) Cervical lesions Genotypes
  • 相关文献

参考文献11

二级参考文献111

共引文献569

同被引文献57

  • 1崔红,冯云霞.宫颈癌筛查技术应用的状况和发展[J].医学信息(医学与计算机应用),2014,0(30):296-296. 被引量:1
  • 2吴瑞芳,刘植华,周庆芝,乌兰娜,王倩,李晴,李霓,刘志红,石菊芳,李瑞珍,张长淮,周艳秋,刘彬,翁雷明,乔友林.深圳女性生殖道人乳头瘤病毒感染与子宫颈上皮内瘤样病变现患率调查及子宫颈癌筛查方法的评价[J].中国医学科学院学报,2010,32(1):90-95. 被引量:57
  • 3陈厚霖,何艳.HPV不同亚型感染与宫颈病变的关系[J].兵团医学,2011(4):1-7. 被引量:5
  • 4Guan P,Howell Jones R,Li N,et al.Human papillomavirus types in115,789 HPV-positive women:A meta-analysis from cervical infection to cancer[J].International journal of cancer,2012,131(10):2349-2359.
  • 5Castellsague X,Munoz N,Pitisuttithum P,et al.End-of-study safety,immunogenicity,and efficacy of quadrivalent HPV(types 6,11,16,18)recombinant vaccine in adult women 24-45 years of age[J].British journal of cancer,2011,105(1):28-37.
  • 6Ingledue K,Cottrell R,Bernard A.College womens knowledge perceptions and preventive behaviors regarding human papillomavirus infection and cervical cancer[J].American journal of health studies,2013,19(1):28-34.
  • 7Ronco G,Dillner J,Elfstrm K M,et al.Efficacy of HPV-based screening for prevention of invasive cervical cancer:follow-up of four European randomised controlled trials[J].The Lancet,2014,383(9916):524-532.
  • 8Cobo F,Talavera P,Concha A,et al.Relationship of human papillomavirus with papillary squamous cell carcinoma of the upper aerodigestive tract:a review[J].Int J Sury Pathol,2008,16(2):127-136.
  • 9Herrero R,Castle PE,Schiffman M,et al.Epidemidvgic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste,Costa Rica[J].J Infect Dis,2005,191(11):1796-1807.
  • 10Munoz N,Bosch FX,Sanjose S,et al.Epidemiologic classification of human papillomavirus types associated with cervical cancer[J].N Engl J Med,2003,348(6):518-527.

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部